Carlos Bustamante is an expert in genomics — the study of genetic variation and its effects on the living world.
He says genomics holds tremendous promise but, so far, virtually all sequenced DNA comes from European blood lines and this presents a problem.
Without greater diversity in the genomic data that is collected, he notes that we cannot fully reap the benefits of this knowledge, particularly in areas such as healthcare.
“Genomics is the new oil,” Bustamante says, of the opportunities that lie ahead. It’s being used for everything from studying rare diseases to developing more effective drugs. Before its potential can be fully realized,however, genomics will have to address its diversity problem. The more genetic variants that are represented in the genomic data collected, the better equipped we’ll be to understand and improve human health.
Join host Russ Altman and geneticist Carlos Bustamante for a peek into the wonders of genomics.
Russ Altman, the Kenneth Fong professor and professor of bioengineering, of genetics, of medicine (general medical discipline), of biomedical data science and, by courtesy, of computer science.